Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 1, 2006 - Issue 3
Submit an article Journal homepage
61
Views
4
CrossRef citations to date
0
Altmetric
Review

Salmeterol/fluticasone combination in the treatment of COPD

K F ChungNational Heart and Lung Institute, Imperial College and Royal Brompton Hospital, London, UKCorrespondence[email protected]
Pages 235-242 | Published online: 20 Oct 2022

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Adamantia Liapikou, Michael Toumbis & Antoni Torres. (2015) Managing the safety of inhaled corticosteroids in COPD and the risk of pneumonia. Expert Opinion on Drug Safety 14:8, pages 1237-1247.
Read now
Jinming Gao & Roy A Pleasants. (2015) Role of the fixed combination of fluticasone and salmeterol in adult Chinese patients with asthma and COPD. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 775-789.
Read now

Articles from other publishers (2)

Rima Hajjo, Dima A. Sabbah & Sanaa K. Bardaweel. (2020) Chemocentric Informatics Analysis: Dexamethasone Versus Combination Therapy for COVID-19 . ACS Omega 5:46, pages 29765-29779.
Crossref
Nina Maria Ainali, Eleftheria Xanthopoulou, Georgia Michailidou, Alexandra Zamboulis & Dimitrios N. Bikiaris. (2020) Microencapsulation of Fluticasone Propionate and Salmeterol Xinafoate in Modified Chitosan Microparticles for Release Optimization. Molecules 25:17, pages 3888.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.